Literature DB >> 17592285

Antireflux surgery, barrett esophagus, and adenocarcinoma: there is still room for doubt.

Glyn G Jamieson.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17592285      PMCID： PMC1899218          DOI： 10.1097/SLA.0b013e318070d3b7

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  13 in total

1.  Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.

Authors:  W Ye; W H Chow; J Lagergren; L Yin; O Nyrén
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

2.  Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis.

Authors:  A Csendes; F Maluenda; I Braghetto; P Csendes; A Henriquez; M S Quesada
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

3.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

4.  Long-term outcome of antireflux surgery in patients with Barrett's esophagus.

Authors:  W L Hofstetter; J H Peters; T R DeMeester; J A Hagen; S R DeMeester; P F Crookes; P Tsai; F Banki; C G Bremner
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

5.  Adenocarcinoma of the esophagus with and without Barrett mucosa.

Authors:  M S Sabel; K Pastore; H Toon; J L Smith
Journal:  Arch Surg       Date:  2000-07

6.  The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure.

Authors:  S Oberg; T R DeMeester; J H Peters; J A Hagen; J J Nigro; S R DeMeester; J Theisen; G M Campos; P F Crookes
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

7.  Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

Authors:  R E Rudolph; T L Vaughan; B E Storer; R C Haggitt; P S Rabinovitch; D S Levine; B J Reid
Journal:  Ann Intern Med       Date:  2000-04-18       Impact factor: 25.391

8.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.

Authors:  S S Devesa; W J Blot; J F Fraumeni
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

9.  Effect of antireflux operation on Barrett's mucosa.

Authors:  W A Williamson; F H Ellis; S P Gibb; D M Shahian; H T Aretz
Journal:  Ann Thorac Surg       Date:  1990-04       Impact factor: 4.330

10.  Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.

Authors:  James M O'Riordan; Patrick J Byrne; Narayanasamy Ravi; Paul W N Keeling; John V Reynolds
Journal:  Am J Surg       Date:  2004-07       Impact factor: 2.565
View more
  3 in total

1.  Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience.

Authors:  S E Attwood; L Lundell; J G Hatlebakk; S Eklund; O Junghard; J-P Galmiche; C Ell; R Fiocca; T Lind
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

2.  MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status.

Authors:  Martin Grimm; Maria Lazariotou; Stefan Kircher; Luisa Stuermer; Christoph Reiber; Andreas Höfelmayr; Stefan Gattenlöhner; Christoph Otto; Christoph T Germer; Burkhard H A von Rahden
Journal:  J Transl Med       Date:  2010-10-14       Impact factor: 5.531

3.  LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus?

Authors:  Burkhard H A von Rahden; Stefan Kircher; Maria Lazariotou; Christoph Reiber; Luisa Stuermer; Christoph Otto; Christoph T Germer; Martin Grimm
Journal:  J Exp Clin Cancer Res       Date:  2011-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.